It will be "knock it out of the park". - efficacy: overwhelming - key secondary endpoints: robustness and consistency - key patient subgroups: robustness and consistency
Nobody said that it will be stopped based on data that are relatively insubstantial.
And once again: number of patient years is a nice marketing tool, but isn't relevant for RRR, statistical significance or any result ... Capice? Subscribe to one more course ...